CINEMARK HOLDINGS INC (CNK) Stock Analyst Ratings
NYSE:CNK - US17243V1026 - Common Stock
26.55 USD
+0.37 (+1.41%)
26.55 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 78% to CNK. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 34.17. This target is 28.7% above the current price.
CNK was analyzed by 17 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about CNK.
In the previous month the buy percentage consensus was at a similar level.
CNK was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-04 | Barrington Research | Reiterate | Outperform -> Outperform |
| 2025-08-04 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-08-04 | Roth Capital | Maintains | Buy -> Buy |
| 2025-07-11 | Wedbush | Upgrade | Neutral -> Outperform |
| 2025-07-10 | Deutsche Bank | Initiate | Buy |
| 2025-07-09 | Roth Capital | Maintains | Buy -> Buy |
| 2025-07-02 | Benchmark | Reiterate | Buy -> Buy |
| 2025-05-05 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-05-05 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-04-28 | Wedbush | Reiterate | Neutral -> Neutral |
| 2025-04-11 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2025-02-20 | Macquarie | Maintains | Outperform -> Outperform |
| 2025-02-20 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-02-20 | Benchmark | Maintains | Buy -> Buy |
| 2025-02-20 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-02-20 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-02-19 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-01-30 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-01-29 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-01-10 | Benchmark | Reiterate | Buy -> Buy |
| 2024-12-03 | Benchmark | Maintains | Buy -> Buy |
| 2024-11-27 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-11-04 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-11-01 | Macquarie | Maintains | Outperform -> Outperform |
| 2024-11-01 | Wedbush | Downgrade | Outperform -> Neutral |
| 2024-11-01 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-10-31 | Barrington Research | Upgrade | Market Perform -> Outperform |
| 2024-10-29 | Wedbush | Maintains | Outperform -> Outperform |
| 2024-10-14 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-10-11 | Morgan Stanley | Maintains | Overweight -> Overweight |